Pain News and Research

Latest Pain News and Research

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

Study: Full Body Illusions can be accompanied by changes in body temperature

Study: Full Body Illusions can be accompanied by changes in body temperature

Nektar completes enrollment in NKTR-102 BEACON trial in patients with metastatic breast cancer

Nektar completes enrollment in NKTR-102 BEACON trial in patients with metastatic breast cancer

HHS Inspector General raises concerns about Medicare policy on observation care

HHS Inspector General raises concerns about Medicare policy on observation care

Study: About 50% of fibromyalgia patients have nerve damage

Study: About 50% of fibromyalgia patients have nerve damage

Study finds doctors not following medical guidelines on back pain

Study finds doctors not following medical guidelines on back pain

Study reveals breast reduction surgery can improve health and quality of life

Study reveals breast reduction surgery can improve health and quality of life

First Edition: July 30, 2013

First Edition: July 30, 2013

WHO aims to increase global rate of breastfeeding for six months to 50% by 2025

WHO aims to increase global rate of breastfeeding for six months to 50% by 2025

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

FDA accepts NDA for MNK-795 oral formulation

FDA accepts NDA for MNK-795 oral formulation

Researchers uncover genetics behind what makes some people susceptible to Takayasu arteritis

Researchers uncover genetics behind what makes some people susceptible to Takayasu arteritis

Hope for treatment of childhood infections may come straight from the gut: Therapeutic poop

Hope for treatment of childhood infections may come straight from the gut: Therapeutic poop

FDA approves Rebiotix's IND application to begin RBX2660 Phase 2 study for recurrent CDI

FDA approves Rebiotix's IND application to begin RBX2660 Phase 2 study for recurrent CDI

Saudi and UK scientists provide detailed picture of MERS coronavirus

Saudi and UK scientists provide detailed picture of MERS coronavirus

First Edition: July 26, 2013

First Edition: July 26, 2013

Viewpoints: Doctors' sway over Medicare pay; hospital rankings not all they seem; legal immigrants' health needs overlooked

Viewpoints: Doctors' sway over Medicare pay; hospital rankings not all they seem; legal immigrants' health needs overlooked

State highlights: D.C. to use cash reserves to pay Medicaid providers off; Texas, Planned Parenthood reach overbilling settlement; Veteran health centers at colleges

State highlights: D.C. to use cash reserves to pay Medicaid providers off; Texas, Planned Parenthood reach overbilling settlement; Veteran health centers at colleges

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Takeda unbinds Phase 3 study of orteronel in patients with mCRPC that progressed post-chemotherapy

Takeda unbinds Phase 3 study of orteronel in patients with mCRPC that progressed post-chemotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.